Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Thromboembolic disorders
Age: Adult
Dose: Intravenous – Initially, 500 ml of a 10% solution in glucose 5%
Frequency: infused over 4-6 hours, followed by 500 ml on the next and subsequent alternate days
Duration: not more than 10 days
Indication: Prophylaxis of postoperative thromboembolic disorders
Age: Adult
Dose: Intravenous – 500 ml of a 10% solution in glucose 5%
Frequency: infused over 4-6 hours during or at the end of the surgery. Dose may be repeated the following day
Duration: continued on alternate days for up to 10 days
Note: for high-risk patient

Child Dose

Clinical InformationAdministration Information
Indication: Thromboembolic disorders
Age: Pediatric (Infants)
Dose: Intravenous – Up to 5 mL/kg
Note: As dextran 40
Indication: Thromboembolic disorders
Age: Pediatric (Children)
Dose: Intravenous – 10 mL/kg
Note: As dextran 40

Renal Dose

Clinical InformationAdministration Information
Condition: Renal Impairment
Dose: Not specified
Note: Extreme caution
Administration
  • For hospital use only
  • Must be given by IV
Side Effect

Drug Interaction

Drug NameRisk Factors
Phenytoin, Carbamazepine
Enzyme inducers
Cimetidine
Enzyme inhibitor

Disease Interaction

Disease NameRisk Factors
Severe Renal Disease
Can worsen kidney function
Cardiac Decompensation
Risk of fluid overload

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.